| Hans-Günter Meyer-Thompson | international
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis.
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis.
Kitchen SA, Campbell TJ, Men S, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T.
Int J Drug Policy. 2022 Mar 1;103:103644. doi: 10.1016/j.drugpo.2022.103644. Epub ahead of print. PMID: 35272107; PMCID: PMC8885322.